Clinical Trial Update: A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia [Phase 1]

View source ↗

Summary

This is an update on an early-phase Phase I study evaluating GFS202A in advanced solid tumors with pre-cachexia or cachexia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• GFS202A (GFS202A)

Snippet

Sponsor: Genfleet Therapeutics (Shanghai) Inc. | Conditions: Cancer Cachexia | Phase 1 | Status: RECRUITING